Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04068129 · ClinicalTrials.gov registry record
Enhanced Housing Photoscreeners 2WIN and GoCheckKids Compared in Burma and Alaska
A clinical trial, sponsored by Alaska Blind Child Discovery.
- Completed
- Registry status
- 162
- Enrollment target
NCT04068129: Completed study, sponsored by Alaska Blind Child Discovery.
NCT04068129 is a clinical trial that has completed, run by Alaska Blind Child Discovery. The registered enrollment target is 162 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04068129 has completed, sponsored by Alaska Blind Child Discovery.
- COMPLETED
- Registry status
- 162 participants
- Enrollment target
Study Summary
"Adaptica" (Padova, Italy) designed a fixed-distance, dark portable tube with power and remote control for the "2WIN: photoscreener. GoChecksKids designed a flash-concentrating case for the iPhone 7+ to more quickly achieve two-axis photoscreen. These devices were compared to confirmatory exams in children and young adults in a remote Burma clinic and in an Alaskan pediatric ophthalmology practice.
Primary Outcome
AAPOS 2003 and 2013 defined ARFs
Interventions
- DEVICE photoscreen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2019-04-15 |
What the finished NCT04068129 record still lists
NCT04068129 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which photoscreen is the first listed.
NCT04068129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04068129 about?
NCT04068129 is a clinical study titled "Enhanced Housing Photoscreeners 2WIN and GoCheckKids Compared in Burma and Alaska". "Adaptica" (Padova, Italy) designed a fixed-distance, dark portable tube with power and remote control for the "2WIN: photoscreener. GoChecksKids designed a flash-concentrating case for the iPhone 7+ to more quickly achieve two-axis photoscreen. These devices were compared to confirmatory exams in c...
What is the current status of trial NCT04068129?
This trial is currently completed. The enrollment target is 162 participants. The study started on 2019-02-11. Estimated completion is 2019-04-15.
What interventions are being tested in trial NCT04068129?
The interventions under investigation include: photoscreen (DEVICE).
Who is sponsoring clinical trial NCT04068129?
This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI